🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users administering substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Response and Content Elimination

Based on TikTok, the service has removed violative material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of users, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

Within minutes of joining one group, a seller shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Product Details and Costs

Within these groups, posts show black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When asked how much time a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious health risks”.